PreveCeutical Medical (FRA:18H0) Research & Development: €0.51 Mil (TTM As of Dec. 2025)


What is PreveCeutical Medical Research & Development?

PreveCeutical Medical FRA:18H0 Research & Development is €0.51 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PreveCeutical Medical's Research & Development for the three months ended in Dec. 2025 was €0.10 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.51 Mil.

PreveCeutical Medical  (FRA:18H0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PreveCeutical Medical Research & Development Related Terms

PreveCeutical Medical Research & Development Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Research & Development Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.11 0.13 0.15 0.49

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.28 0.12 0.01 0.10

PreveCeutical Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.51 Mil mean?
PreveCeutical Medical (FRA:18H0) has a Research & Development of €0.51 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on PreveCeutical Medical and its competitors.
Is PreveCeutical Medical's Research & Development too high?
PreveCeutical Medical's current Research & Development is €0.51 Mil.
How does PreveCeutical Medical's Research & Development compare to VRTX and REGN?
PreveCeutical Medical's Research & Development of €0.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current Research & Development is €0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current Research & Development of €0.51 Mil. The current Research & Development is €0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current Research & Development is €0.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges PRVCF:USAPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.